Atossa Therapeutics
ATOS
#9333
Rank
ยฃ69.06 M
Marketcap
ยฃ0.53
Share price
-13.37%
Change (1 day)
-36.90%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ0.57 M-69.34%
2024ยฃ1.86 M265.91%
2023ยฃ0.5 M-93.57%
2022ยฃ7.92 M-92.88%
2021ยฃ0.11 B731.9%
2020ยฃ13.37 M-10.09%
2019ยฃ14.87 M138.47%
2018ยฃ6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ57.52 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ14.78 Mยฃ32.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ23.3 Mยฃ36.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
N/Aยฃ0.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ0.05 Mยฃ13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.8 Mยฃ3.65 M๐Ÿ‡บ๐Ÿ‡ธ USA